Literature DB >> 25211645

Evaluating novel therapies during the Ebola epidemic.

Steven Joffe1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25211645     DOI： 10.1001/jama.2014.12867

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  27 in total

Review 1.  Improving vaccine trials in infectious disease emergencies.

Authors:  Marc Lipsitch; Nir Eyal
Journal:  Science       Date:  2017-07-14       Impact factor: 47.728

2.  Evolving Challenges and Research-Needs Concerning Ebola.

Authors:  Robert Klitzman
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

3.  Treatment of Ebola virus disease.

Authors:  Yazdan Yazdanpanah; Jose Ramon Arribas; Denis Malvy
Journal:  Intensive Care Med       Date:  2014-11-11       Impact factor: 17.440

4.  Selecting the right tool for the job.

Authors:  Arthur L Caplan; Carolyn Plunkett; Bruce Levin
Journal:  Am J Bioeth       Date:  2015       Impact factor: 11.229

Review 5.  Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision-making.

Authors:  Thomas M Caparrotta; James W Dear; Helen M Colhoun; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2019-07-24       Impact factor: 4.335

6.  Ethical and epistemic issues in the design and conduct of pragmatic stepped-wedge cluster randomized clinical trials.

Authors:  Carole A Federico; Patrick J Heagerty; John Lantos; Pearl O'Rourke; Vasiliki Rahimzadeh; Jeremy Sugarman; Kevin Weinfurt; David Wendler; Benjamin S Wilfond; David Magnus
Journal:  Contemp Clin Trials       Date:  2022-02-15       Impact factor: 2.261

Review 7.  Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks.

Authors:  Azizul Haque; Didier Hober; Joel Blondiaux
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

Review 8.  Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks.

Authors:  Marc Lipsitch; Christl A Donnelly; Christophe Fraser; Isobel M Blake; Anne Cori; Ilaria Dorigatti; Neil M Ferguson; Tini Garske; Harriet L Mills; Steven Riley; Maria D Van Kerkhove; Miguel A Hernán
Journal:  PLoS Negl Trop Dis       Date:  2015-07-16

9.  Evaluating clinical trial designs for investigational treatments of Ebola virus disease.

Authors:  Ben S Cooper; Maciej F Boni; Wirichada Pan-ngum; Nicholas P J Day; Peter W Horby; Piero Olliaro; Trudie Lang; Nicholas J White; Lisa J White; John Whitehead
Journal:  PLoS Med       Date:  2015-04-14       Impact factor: 11.069

10.  Randomised controlled trials for Ebola: practical and ethical issues.

Authors:  Clement Adebamowo; Oumou Bah-Sow; Fred Binka; Roberto Bruzzone; Arthur Caplan; Jean-François Delfraissy; David Heymann; Peter Horby; Pontiano Kaleebu; Jean-Jacques Muyembe Tamfum; Piero Olliaro; Peter Piot; Abdul Tejan-Cole; Oyewale Tomori; Aissatou Toure; Els Torreele; John Whitehead
Journal:  Lancet       Date:  2014-10-13       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.